Mostrando 34,621 - 34,640 Resultados de 34,656 Para Buscar 'biguru~', tiempo de consulta: 1.60s Limitar resultados
  1. 34621
    “…All mice had established disease at time of injection. As shown in Figure 1, the severity of arthritis (Fig. 1a), paw thickness (Fig. 1b), and the number of arthritic paws (Fig. 1c) were all significantly reduced in the Ad-mIL-4 group, compared with the saline- and Ad-eGFP-treated groups. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  2. 34622
    por Joseph, Don R.
    Publicado 1911
    “…In one instance, in which figures are given, the drug was administered in a five per cent. solution. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  3. 34623
    “…RESULTS: Both need and demand are important estimates in planning for services but contain many difficulties in moving from the theory of measurement to the practicalities of establishing these figures. Furthermore, the simple quantum of need or demand is limited in its usefulness unless it is matched with consideration of different treatment types and their relative intensity, and/or explored as a function of geography and subpopulation. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 34624
    “…Larger studies are needed to confirm our findings and help guide management of pts with hematologic malignancies during the SARS-CoV-2 pandemic. [Figure: see text] DISCLOSURES: Altman:Bristol-Myers Squibb: Consultancy; Janssen: Consultancy; Immune Pharmaceuticals: Consultancy; Syros: Consultancy; Genentech: Research Funding; Novartis: Consultancy; Amphivena: Research Funding; Amgen: Research Funding; Aprea: Research Funding; ImmunoGen: Research Funding; Celgene: Research Funding; Boehringer Ingelheim: Research Funding; Fujifilm: Research Funding; Kartos: Research Funding; AbbVie: Other: advisory board, Research Funding; Kura Oncology: Other: Scientific Advisory Board - no payment accepted, Research Funding; BioSight: Other: No payment but was reimbursed for travel , Research Funding; Daiichi Sankyo: Other: Advisory Board - no payment but was reimbursed for travel; Agios: Other: advisory board, Research Funding; Glycomimetics: Other: Data safety and monitoring committee; Astellas: Other: Advisory Board, Speaker (no payment), Steering Committee (no payment), Research Funding; Theradex: Other: Advisory Board; ASH: Consultancy; Cancer Expert Now: Consultancy; France Foundation: Consultancy; PeerView: Consultancy; PrIME Oncology: Consultancy. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 34625
    “…Updated data will be presented at the meeting. [Figure: see text] DISCLOSURES: Nadeem:Sanofi: Consultancy, Membership on an entity’s Board of Directors or advisory committees; Amgen: Membership on an entity’s Board of Directors or advisory committees; Adaptive: Membership on an entity’s Board of Directors or advisory committees; Janssen: Consultancy, Honoraria, Other: TRAVEL, ACCOMMODATIONS, EXPENSES; Celgene: Consultancy, Honoraria, Membership on an entity’s Board of Directors or advisory committees, Other: TRAVEL, ACCOMMODATIONS, EXPENSES; Takeda: Consultancy, Membership on an entity’s Board of Directors or advisory committees, Other: TRAVEL, ACCOMMODATIONS, EXPENSES. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 34626
  7. 34627
    “…Acknowledgment The iCMLf CANDID Study would not have been possible without the 186 physicians who contributed case reports. [Figure: see text] DISCLOSURES: Pagnano:  Novartis: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Astellas: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Pintpharma: Other: Lecture; EMS: Other: Lecture; Jansenn: Other: Lecture. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 34628
    por Velasco, Pablo, Longo, Filomena, Piolatto, Andrea, Bardón-Cancho, Eduardo J., Ponce-Salas, Beatriz, Flevari, Pagona, Voskaridou, Ersi, Biemond, Bart J., Nur, Erfan, Delaporta, Polyxeni, Besse-Hammer, Tatiana, Ruiz-Llobet, Anna, Raso, Simona, Spasiano, Anna, Guerzoni, Maria Elena, Beneitez-Pastor, David, Dedeken, Laurence, Pepe, Alessia, Rosso, Rosamaria, Kunz, Joachim B., de Montalembert, Mariane, Campisi, Saveria, Glenthøj, Andreas, Gonzalez Urdiales, Paula, Benghiat, Fleur Samantha, Azerad, Marie-Agnès, Saunders, Christopher J., Ferreira Faria, Teresa, Casini, Tommaso, Bagnato, Sabrina, Van de Velde, Ann, Labarque, Veerle, Bertoni, Elisa, Van Damme, An, Diamantidis, Michael D., Russo, Roberta, Stiakaki, Eftichia, Quota, Alessandra, Christou, Soteroula, Teles, Maria Jose, Lafiatis, Ioannis, Kerkhoffs, Jean-Louis, Argüello Marina, María, Lorite, Mikael, Rodriguez, Alexis, Iolascon, Achille, Taher, Ali T., Colombatti, Raffaella, Roy, Noemi, Mañú Pereira, Maria Del Mar
    Publicado 2021
    “…Results between similar sized cohorts of RBCD patients vary between each other and those presented here, highlighting the importance of collecting all of these small cohorts together to ensure adequate statistical power so that definitive risk factors (eg. age, genotype, comorbidities) can be reliably identified and used to guide management of patients with these rare disorders in the light of the ongoing pandemic. [Figure: see text] DISCLOSURES: Longo:  Bristol Myers Squibb: Honoraria; BlueBird Bio: Honoraria. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 34629
    “…However, both the reports are an underestimate of the true figures. The pandemic however has now provided an opportunity for cross- sectoral collaboration for suicide prevention rather than restricting suicide prevention to the health sector Symposium Proposal: Digital Phenotyping in Mental Health This symposium explores the emerging field of digital phenotyping in mental health. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 34630
    “…ABSTRACT: The objectives of this study were to elucidate the effect of different high-concentration levels of inert gases (Ar and N(2)) on heme-pigment solutions and on the color of the blood, meat, and small intestine of rabbits; and to figure out the proper concentration level of inert gas (Ar or N(2)) for the complete stunning of the rabbit. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 34631
  12. 34632
    por Deb, Suman
    Publicado 2022
    “…The sensitivity of hadronic resonances to rescattering and regeneration processes in the hadronic phases is depicted in Figure~\ref{fig_hadronic_phase}. The major objectives of this thesis are to understand the interplay of various processes in the hadronic phase with event shape and high-multiplicity dependence study of $\rm{K}^{*\pm}$ meson production using ALICE detectors at the LHC (CERN). …”
    Enlace del recurso
  13. 34633
    “…RESULTS: A-SAA mRNA expression was detected using RT-PCR in all eight synovial tissue samples studied. Figure 1 demonstrates RT-PCR products generated using synovial tissue from three representative RA patients. …”
    Enlace del recurso
    Enlace del recurso
    Texto
  14. 34634
    “…To help convey the meaning of this coefficient, we generated marginal effects of SNAP participation based on SNAP generosity, setting all covariates equal to their means. This figure shows a small negative effect of SNAP participation at the lowest levels of generosity (a score of around 4, the sample minimum). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 34635
    “…Taniborbactam is currently undergoing phase 3 clinical trials in combination with cefepime (FEP; Fig 1) as part of the β-lactam-BLI (BL-BLI) combination FEP-taniborbactam (FTB). [Image: see text] Figure 1. Structures of taniborbactam and cefepime. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 34636
    “…We are currently analysing the response to a second vaccine injection and responses to sequential doses of vaccination across the whole cohort will be presented. [Figure: see text] DISCLOSURES: Harrington:  Bristol Myers Squibb: Research Funding; Incyte: Honoraria. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 34637
  18. 34638
    por Lazzari, Federico
    Publicado 2019
    “…The ghost rate in this simulation turned out to be quite high (∼ 50%), but this figure is similar to what obtained with software when using only a portion of the available tracking layers, and does not indicate a problem for the complete system. …”
    Enlace del recurso
  19. 34639
    “…The CCNW is steered by a multidisciplinary committee (Figure 1) that is empowered with the generative, managerial, and fiscal responsibilities to enable the required changes to take place. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 34640
    “…JEWN, MI and JM are co-first authors and PV, HM and AR are co-senior authors. [Figure: see text] DISCLOSURES: Munoz:  Physicians' Education Resource: Honoraria; Seattle Genetics: Honoraria; Bayer: Research Funding; Gilead/Kite Pharma: Research Funding; Celgene: Research Funding; Merck: Research Funding; Portola: Research Funding; Incyte: Research Funding; Genentech: Research Funding; Pharmacyclics: Research Funding; Seattle Genetics: Research Funding; Janssen: Research Funding; Millennium: Research Funding; Gilead/Kite Pharma, Kyowa, Bayer, Pharmacyclics/Janssen, Seattle Genetics, Acrotech/Aurobindo, Beigene, Verastem, AstraZeneca, Celgene/BMS, Genentech/Roche.: Speakers Bureau; Pharmacyclics/Abbvie, Bayer, Gilead/Kite Pharma, Pfizer, Janssen, Juno/Celgene, BMS, Kyowa, Alexion, Beigene, Fosunkite, Innovent, Seattle Genetics, Debiopharm, Karyopharm, Genmab, ADC Therapeutics, Epizyme, Beigene, Servier: Consultancy; Targeted Oncology: Honoraria; OncView: Honoraria; Kyowa: Honoraria. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS